Cambrex is the leading small molecule CDMO that provides drug substance, drug product and analytical services across the entire drug lifecycle.
Founded date: 1981
Investors 1
| Date | Name | Website |
| - | SK Capital... | skcapitalp... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 14.03.2024 | Noramco Announces Strategic Alignment with Purisys and Halo ... | -The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmac... | venturebea... |
| 14.05.2019 | Sekisui Diagnostics Invests $1.9M in Microbial Biopharma CDM... | Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre a... | citybizlis... |
| 26.08.2015 | Halo Pharmaceutical Makes Key Additions to Management Team | Whippany, New Jersey, August 26, 2015 – Halo Pharmaceutical, a rapidly growing Contract Development ... | skcapitalp... |
| 06.01.2015 | SK Capital Makes Strategic Investment in Halo Pharmaceutical | NEW YORK, January 6, 2015 – NEW YORK — (BUSINESS WIRE) — SK Capital Partners, a private investment f... | skcapitalp... |